Search hospitals > Pennsylvania > Lewisburg
Geisinger Medical Oncology-Lewisburg
Claim this profileLewisburg, Pennsylvania 17837
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Lymphoma
260 reported clinical trials
19 medical researchers
Summary
Geisinger Medical Oncology-Lewisburg is a medical facility located in Lewisburg, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Lymphoma and other specialties. Geisinger Medical Oncology-Lewisburg is involved with conducting 260 clinical trials across 324 conditions. There are 19 research doctors associated with this hospital, such as Raghava Reddy Levaka Veera, Joseph J. Vadakara, Sorab Gupta, and Anand Mahadevan.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
ER positive
HER2 negative
Top PIs
Raghava Reddy Levaka VeeraGeisinger Wyoming Valley/Henry Cancer Center4 years of reported clinical research
Expert in Cancer
Studies Adenocarcinoma
19 reported clinical trials
43 drugs studied
Joseph J. VadakaraGeisinger Medical Center5 years of reported clinical research
Studies Leukemia
Studies Lymphoma
20 reported clinical trials
60 drugs studied
Sorab GuptaGeisinger Medical Center3 years of reported clinical research
Studies Cancer
Studies Squamous Cell Carcinoma
13 reported clinical trials
24 drugs studied
Anand MahadevanGeisinger Medical Center5 years of reported clinical research
Studies Cancer
Studies Glioblastoma
11 reported clinical trials
25 drugs studied
Clinical Trials running at Geisinger Medical Oncology-Lewisburg
Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Small Cell Lung Cancer
Melanoma
Multiple Myeloma
Cutaneous Melanoma
Anal Cancer
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Whole Brain Radiotherapy + Stereotactic Radiosurgery
for Brain Metastasis
This phase III trial compares the effect of adding whole brain radiotherapy with hippocampal avoidance and memantine to stereotactic radiosurgery versus stereotactic radiosurgery alone in treating patients with cancer that has spread to the brain and come back in other areas of the brain after earlier stereotactic radiosurgery. Hippocampus avoidance during whole-brain radiation therapy decreases the amount of radiation that is delivered to the hippocampus, which is a brain structure that is important for memory. The medicine memantine is also often given with whole brain radiation therapy because it may decrease the risk of side effects of radiation on thinking and memory. Stereotactic radiosurgery delivers a high dose of radiation only to the small areas of cancer in the brain and avoids the surrounding normal brain tissue. Adding whole brain radiotherapy with hippocampal avoidance and memantine to stereotactic radiosurgery may be effective in shrinking or stabilizing cancer that has spread to the brain and returned in other areas of the brain after receiving stereotactic radiosurgery.
Recruiting2 awards Phase 312 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Geisinger Medical Oncology-Lewisburg?
Geisinger Medical Oncology-Lewisburg is a medical facility located in Lewisburg, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Lymphoma and other specialties. Geisinger Medical Oncology-Lewisburg is involved with conducting 260 clinical trials across 324 conditions. There are 19 research doctors associated with this hospital, such as Raghava Reddy Levaka Veera, Joseph J. Vadakara, Sorab Gupta, and Anand Mahadevan.